| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 1.82e-06 | 8 | 65 | 3 | GO:0004169 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 1.97e-06 | 28 | 65 | 4 | GO:0000030 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 9.20e-06 | 13 | 65 | 3 | GO:0004126 | |
| GeneOntologyMolecularFunction | UDP-glucose:glycoprotein glucosyltransferase activity | 1.04e-05 | 2 | 65 | 2 | GO:0003980 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 5.57e-05 | 23 | 65 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.37e-05 | 211 | 65 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.13e-04 | 29 | 65 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | deaminase activity | 1.83e-04 | 34 | 65 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.18e-04 | 36 | 65 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.46e-04 | 288 | 65 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.33e-04 | 120 | 65 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 7.95e-04 | 13 | 65 | 2 | GO:0035251 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.37e-03 | 17 | 65 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.72e-03 | 19 | 65 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 2.31e-03 | 22 | 65 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.53e-03 | 23 | 65 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.22e-03 | 26 | 65 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor binding | 4.00e-03 | 29 | 65 | 2 | GO:0005104 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.11e-03 | 200 | 65 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 4.62e-03 | 103 | 65 | 3 | GO:0004553 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | POMT2 THSD4 ADAMTSL1 COL17A1 ADAMTS7 ADAMTS6 ADAMTS17 ANTXR1 SEMA5A LOXL3 FLRT2 POMT1 ADAMTSL2 | 9.49e-11 | 377 | 63 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | POMT2 THSD4 ADAMTSL1 COL17A1 ADAMTS7 ADAMTS6 ADAMTS17 ANTXR1 SEMA5A LOXL3 FLRT2 POMT1 ADAMTSL2 | 9.80e-11 | 378 | 63 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | POMT2 THSD4 ADAMTSL1 COL17A1 ADAMTS7 ADAMTS6 ADAMTS17 ANTXR1 SEMA5A LOXL3 FLRT2 POMT1 ADAMTSL2 | 1.01e-10 | 379 | 63 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | mannosylation | 1.42e-08 | 26 | 63 | 5 | GO:0097502 | |
| GeneOntologyBiologicalProcess | protein mannosylation | 9.53e-07 | 25 | 63 | 4 | GO:0035268 | |
| GeneOntologyBiologicalProcess | glycosylation | 1.62e-06 | 270 | 63 | 8 | GO:0070085 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 3.21e-06 | 10 | 63 | 3 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 5.86e-06 | 12 | 63 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 7.35e-06 | 41 | 63 | 4 | GO:1901658 | |
| GeneOntologyBiologicalProcess | UDP-glucosylation | 9.18e-06 | 2 | 63 | 2 | GO:0097359 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 9.65e-06 | 14 | 63 | 3 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 9.65e-06 | 14 | 63 | 3 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 9.65e-06 | 14 | 63 | 3 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 9.65e-06 | 14 | 63 | 3 | GO:0045006 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 1.15e-05 | 252 | 63 | 7 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 1.15e-05 | 252 | 63 | 7 | GO:0006486 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 1.48e-05 | 16 | 63 | 3 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 1.48e-05 | 16 | 63 | 3 | GO:0046133 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | POMT2 PIGB CWH43 TMTC4 ADAMTS7 ABHD10 UGGT1 NUS1 UGGT2 APOBEC1 POMT1 APOBEC3B ELOVL2 APOBEC3A | 1.53e-05 | 1226 | 63 | 14 | GO:1901135 |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.77e-05 | 51 | 63 | 4 | GO:0050919 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 2.14e-05 | 18 | 63 | 3 | GO:0046135 | |
| GeneOntologyBiologicalProcess | protein O-linked mannosylation | 2.54e-05 | 19 | 63 | 3 | GO:0035269 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 2.54e-05 | 19 | 63 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | positive regulation of protein O-linked glycosylation | 2.75e-05 | 3 | 63 | 2 | GO:1904100 | |
| GeneOntologyBiologicalProcess | regulation of protein O-linked glycosylation | 2.75e-05 | 3 | 63 | 2 | GO:1904098 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 4.75e-05 | 430 | 63 | 8 | GO:0009100 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 6.72e-05 | 26 | 63 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 7.54e-05 | 27 | 63 | 3 | GO:0006213 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 8.60e-05 | 76 | 63 | 4 | GO:0006487 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 1.06e-04 | 357 | 63 | 7 | GO:0009101 | |
| GeneOntologyBiologicalProcess | DNA modification | 1.15e-04 | 31 | 63 | 3 | GO:0006304 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 1.26e-04 | 32 | 63 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | UDP-alpha-D-glucose metabolic process | 1.37e-04 | 6 | 63 | 2 | GO:0006011 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.37e-04 | 6 | 63 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.37e-04 | 6 | 63 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 1.81e-04 | 92 | 63 | 4 | GO:0072527 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 1.96e-04 | 37 | 63 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 2.13e-04 | 96 | 63 | 4 | GO:1901657 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 3.75e-04 | 46 | 63 | 3 | GO:0072529 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 3.77e-04 | 736 | 63 | 9 | GO:1901137 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 4.26e-04 | 48 | 63 | 3 | GO:0009119 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 5.39e-04 | 52 | 63 | 3 | GO:0071526 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression via chromosomal CpG island demethylation | 9.40e-04 | 15 | 63 | 2 | GO:0044029 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 1.06e-03 | 147 | 63 | 4 | GO:0042157 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.07e-03 | 16 | 63 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 1.18e-03 | 68 | 63 | 3 | GO:0009116 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.52e-03 | 19 | 63 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.52e-03 | 19 | 63 | 2 | GO:0060050 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 1.68e-03 | 20 | 63 | 2 | GO:0039692 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.78e-03 | 285 | 63 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.80e-03 | 286 | 63 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.94e-03 | 173 | 63 | 4 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.02e-03 | 175 | 63 | 4 | GO:0009582 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 ADAMTSL1 COL17A1 ADAMTS7 ADAMTS6 ADAMTS17 RTN4RL1 LOXL3 FLRT2 FLRT1 NYX RTN4RL2 SSPOP ADAMTSL2 OTOG | 7.27e-10 | 656 | 63 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 ADAMTSL1 COL17A1 ADAMTS7 ADAMTS6 ADAMTS17 RTN4RL1 LOXL3 FLRT2 FLRT1 NYX RTN4RL2 SSPOP ADAMTSL2 OTOG | 7.58e-10 | 658 | 63 | 15 | GO:0030312 |
| Domain | TSP_1 | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS17 SEMA5A C8A SSPOP UNC5D ADAMTSL2 | 1.36e-18 | 63 | 62 | 12 | PF00090 |
| Domain | TSP1 | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS17 SEMA5A C8A SSPOP UNC5D ADAMTSL2 | 2.04e-18 | 65 | 62 | 12 | SM00209 |
| Domain | TSP1_rpt | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS17 SEMA5A C8A SSPOP UNC5D ADAMTSL2 | 2.04e-18 | 65 | 62 | 12 | IPR000884 |
| Domain | TSP1 | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS17 SEMA5A C8A SSPOP UNC5D ADAMTSL2 | 2.04e-18 | 65 | 62 | 12 | PS50092 |
| Domain | PLAC | 2.74e-11 | 19 | 62 | 6 | PS50900 | |
| Domain | PLAC | 2.74e-11 | 19 | 62 | 6 | IPR010909 | |
| Domain | PLAC | 6.69e-10 | 14 | 62 | 5 | PF08686 | |
| Domain | ADAM_spacer1 | 1.10e-08 | 23 | 62 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.10e-08 | 23 | 62 | 5 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.38e-08 | 24 | 62 | 5 | IPR013273 | |
| Domain | APOBEC_N | 7.50e-06 | 12 | 62 | 3 | PF08210 | |
| Domain | APOBEC_N | 7.50e-06 | 12 | 62 | 3 | IPR013158 | |
| Domain | PMT_4TMC | 1.08e-05 | 2 | 62 | 2 | PF16192 | |
| Domain | UDP-g_GGtrans | 1.08e-05 | 2 | 62 | 2 | IPR009448 | |
| Domain | PMT_4TMC | 1.08e-05 | 2 | 62 | 2 | IPR032421 | |
| Domain | PMT | 1.08e-05 | 2 | 62 | 2 | PF02366 | |
| Domain | Glyco_trans_39/83 | 1.08e-05 | 2 | 62 | 2 | IPR003342 | |
| Domain | UDP-g_GGTase | 1.08e-05 | 2 | 62 | 2 | PF06427 | |
| Domain | Cys-rich_flank_reg_C | 1.21e-05 | 90 | 62 | 5 | IPR000483 | |
| Domain | LRRCT | 1.21e-05 | 90 | 62 | 5 | SM00082 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.24e-05 | 14 | 62 | 3 | IPR016192 | |
| Domain | LRRNT | 1.83e-05 | 98 | 62 | 5 | IPR000372 | |
| Domain | LRRNT | 1.83e-05 | 98 | 62 | 5 | SM00013 | |
| Domain | Cytidine_deaminase-like | 2.29e-05 | 17 | 62 | 3 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.29e-05 | 17 | 62 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.29e-05 | 17 | 62 | 3 | IPR002125 | |
| Domain | LRRNT | 2.85e-05 | 53 | 62 | 4 | PF01462 | |
| Domain | GlyclTrfase_39-like | 6.48e-05 | 4 | 62 | 2 | IPR027005 | |
| Domain | Sema | 1.47e-04 | 31 | 62 | 3 | SM00630 | |
| Domain | Semap_dom | 1.47e-04 | 31 | 62 | 3 | IPR001627 | |
| Domain | Sema | 1.47e-04 | 31 | 62 | 3 | PF01403 | |
| Domain | SEMA | 1.47e-04 | 31 | 62 | 3 | PS51004 | |
| Domain | PSI | 1.61e-04 | 32 | 62 | 3 | PF01437 | |
| Domain | Plexin_repeat | 1.61e-04 | 32 | 62 | 3 | IPR002165 | |
| Domain | LRR_8 | 2.58e-04 | 171 | 62 | 5 | PF13855 | |
| Domain | Leu-rich_rpt | 2.75e-04 | 271 | 62 | 6 | IPR001611 | |
| Domain | Peptidase_M12B_N | 2.92e-04 | 39 | 62 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.92e-04 | 39 | 62 | 3 | PF01562 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.02e-04 | 177 | 62 | 5 | IPR003591 | |
| Domain | LRR_TYP | 3.02e-04 | 177 | 62 | 5 | SM00369 | |
| Domain | DISINTEGRIN_1 | 3.15e-04 | 40 | 62 | 3 | PS00427 | |
| Domain | Reprolysin | 3.15e-04 | 40 | 62 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.15e-04 | 40 | 62 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.15e-04 | 40 | 62 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.15e-04 | 40 | 62 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.39e-04 | 41 | 62 | 3 | IPR001762 | |
| Domain | PSI | 4.19e-04 | 44 | 62 | 3 | IPR016201 | |
| Domain | PSI | 4.78e-04 | 46 | 62 | 3 | SM00423 | |
| Domain | MIR | 4.80e-04 | 10 | 62 | 2 | PS50919 | |
| Domain | MIR | 4.80e-04 | 10 | 62 | 2 | PF02815 | |
| Domain | MIR | 4.80e-04 | 10 | 62 | 2 | SM00472 | |
| Domain | MIR_motif | 4.80e-04 | 10 | 62 | 2 | IPR016093 | |
| Domain | - | 6.73e-04 | 321 | 62 | 6 | 3.80.10.10 | |
| Domain | TIL | 7.00e-04 | 12 | 62 | 2 | PF01826 | |
| Domain | C8 | 7.00e-04 | 12 | 62 | 2 | PF08742 | |
| Domain | L_dom-like | 7.54e-04 | 328 | 62 | 6 | IPR032675 | |
| Domain | LRR_1 | 7.96e-04 | 219 | 62 | 5 | PF00560 | |
| Domain | Unchr_dom_Cys-rich | 8.26e-04 | 13 | 62 | 2 | IPR014853 | |
| Domain | C8 | 8.26e-04 | 13 | 62 | 2 | SM00832 | |
| Domain | TIL_dom | 9.62e-04 | 14 | 62 | 2 | IPR002919 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.11e-03 | 15 | 62 | 2 | PS51747 | |
| Domain | VWD | 1.26e-03 | 16 | 62 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.26e-03 | 16 | 62 | 2 | IPR001846 | |
| Domain | VWFD | 1.26e-03 | 16 | 62 | 2 | PS51233 | |
| Domain | VWD | 1.26e-03 | 16 | 62 | 2 | PF00094 | |
| Domain | - | 1.51e-03 | 663 | 62 | 8 | 2.60.40.10 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.60e-03 | 18 | 62 | 2 | PS00754 | |
| Domain | VWC_out | 1.79e-03 | 19 | 62 | 2 | SM00215 | |
| Domain | SNF | 1.79e-03 | 19 | 62 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.79e-03 | 19 | 62 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.79e-03 | 19 | 62 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 1.79e-03 | 19 | 62 | 2 | IPR000175 | |
| Domain | Semaphorin | 1.98e-03 | 20 | 62 | 2 | IPR027231 | |
| Domain | fn3 | 2.06e-03 | 162 | 62 | 4 | PF00041 | |
| Domain | Ig-like_fold | 2.23e-03 | 706 | 62 | 8 | IPR013783 | |
| Domain | MetalloPept_cat_dom | 2.47e-03 | 81 | 62 | 3 | IPR024079 | |
| Domain | - | 2.47e-03 | 81 | 62 | 3 | 3.40.390.10 | |
| Domain | Cys_knot_C | 3.10e-03 | 25 | 62 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.10e-03 | 25 | 62 | 2 | PS01225 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | POMT2 THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A POMT1 SSPOP ADAMTSL2 | 2.14e-16 | 68 | 47 | 11 | M27303 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A SSPOP ADAMTSL2 | 4.44e-15 | 39 | 47 | 9 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A SSPOP ADAMTSL2 | 4.44e-15 | 39 | 47 | 9 | MM15165 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | POMT2 THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 NUS1 ADAMTS17 SEMA5A POMT1 SSPOP ADAMTSL2 | 2.87e-14 | 143 | 47 | 12 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | POMT2 THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A POMT1 SSPOP ADAMTSL2 | 4.87e-14 | 109 | 47 | 11 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | POMT2 THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A POMT1 SSPOP ADAMTSL2 | 5.98e-14 | 111 | 47 | 11 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | POMT2 THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 NUS1 ADAMTS17 SI SEMA5A POMT1 SSPOP ADAMTSL2 | 1.03e-12 | 250 | 47 | 13 | M27554 |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.92e-06 | 8 | 47 | 3 | M27683 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | POMT2 THSD4 PIGB ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 UGGT1 NUS1 ADAMTS17 RTN4RL1 SEMA5A UGGT2 POMT1 RTN4RL2 SSPOP ADAMTSL2 | 2.52e-06 | 1475 | 47 | 17 | M19806 |
| Pathway | REACTOME_MRNA_EDITING | 4.10e-06 | 10 | 47 | 3 | M27709 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK | 1.08e-04 | 5 | 47 | 2 | M47610 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | POMT2 THSD4 PIGB ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 NUS1 ADAMTS17 SEMA5A POMT1 RTN4RL2 SSPOP ADAMTSL2 | 1.14e-04 | 1389 | 47 | 14 | MM15307 |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 2.26e-04 | 7 | 47 | 2 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 3.86e-04 | 9 | 47 | 2 | MM15445 | |
| Pathway | KEGG_AXON_GUIDANCE | 8.80e-04 | 129 | 47 | 4 | M5539 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 2.19e-03 | 21 | 47 | 2 | M27875 | |
| Pubmed | THSD4 ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS17 SEMA5A SSPOP ADAMTSL2 | 2.62e-16 | 75 | 67 | 10 | 20637190 | |
| Pubmed | 7.72e-10 | 52 | 67 | 6 | 26633812 | ||
| Pubmed | APOBEC deaminases-mutases with defensive roles for immunity. | 2.38e-07 | 7 | 67 | 3 | 19911124 | |
| Pubmed | 1.12e-06 | 11 | 67 | 3 | 12683974 | ||
| Pubmed | FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. | 1.48e-06 | 12 | 67 | 3 | 21673655 | |
| Pubmed | Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2. | 3.66e-06 | 2 | 67 | 2 | 19880378 | |
| Pubmed | Physical and functional association of human protein O-mannosyltransferases 1 and 2. | 3.66e-06 | 2 | 67 | 2 | 16698797 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 10694380 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 26320772 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 35020946 | ||
| Pubmed | Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression. | 3.66e-06 | 2 | 67 | 2 | 28825669 | |
| Pubmed | POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study. | 3.66e-06 | 2 | 67 | 2 | 18513969 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27155849 | ||
| Pubmed | Clinical implications of APOBEC3A and 3B expression in patients with breast cancer. | 3.66e-06 | 2 | 67 | 2 | 32176735 | |
| Pubmed | POMT1 and POMT2 gene mutations result in 2 cases of alpha-dystroglycanopathy. | 3.66e-06 | 2 | 67 | 2 | 34565739 | |
| Pubmed | Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer. | 3.66e-06 | 2 | 67 | 2 | 38033156 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 38499553 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 26258849 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 35194151 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21995620 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 16887026 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 28512129 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 14699049 | ||
| Pubmed | HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. | 3.66e-06 | 2 | 67 | 2 | 18005940 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24728294 | ||
| Pubmed | APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication. | 3.66e-06 | 2 | 67 | 2 | 26832400 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 31404619 | ||
| Pubmed | Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer. | 3.66e-06 | 2 | 67 | 2 | 34873230 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 36810712 | ||
| Pubmed | APOBEC3A/B deletion polymorphism and endometrial cancer risk. | 3.66e-06 | 2 | 67 | 2 | 36394079 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24140206 | ||
| Pubmed | APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis. | 3.66e-06 | 2 | 67 | 2 | 35017684 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 33320095 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 25298230 | ||
| Pubmed | Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B. | 3.66e-06 | 2 | 67 | 2 | 27991903 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 31862729 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27496766 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23599896 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 12694398 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 12913004 | ||
| Pubmed | Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active. | 3.66e-06 | 2 | 67 | 2 | 24415556 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 35859169 | ||
| Pubmed | Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2. | 3.66e-06 | 2 | 67 | 2 | 21782786 | |
| Pubmed | Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis. | 1.10e-05 | 3 | 67 | 2 | 35902635 | |
| Pubmed | Population stratification of a common APOBEC gene deletion polymorphism. | 1.10e-05 | 3 | 67 | 2 | 17447845 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 39150943 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31322199 | ||
| Pubmed | APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. | 1.10e-05 | 3 | 67 | 2 | 16407327 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10469298 | ||
| Pubmed | Agenesis of the corpus callosum in Nogo receptor deficient mice. | 1.10e-05 | 3 | 67 | 2 | 27339102 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10644439 | ||
| Pubmed | APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. | 1.10e-05 | 3 | 67 | 2 | 22457529 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30135250 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 18490429 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 27643540 | ||
| Pubmed | [Human Papillomavirus Carcinogenesis Mediated by APOBEC Mutagenesis]. | 1.10e-05 | 3 | 67 | 2 | 30606934 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 38105291 | ||
| Pubmed | The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. | 1.10e-05 | 3 | 67 | 2 | 36100631 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 14667842 | ||
| Pubmed | POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies. | 1.10e-05 | 3 | 67 | 2 | 20816175 | |
| Pubmed | The nogo receptor family restricts synapse number in the developing hippocampus. | 1.10e-05 | 3 | 67 | 2 | 22325200 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 11278576 | ||
| Pubmed | Super-complexes of adhesion GPCRs and neural guidance receptors. | 1.10e-05 | 3 | 67 | 2 | 27091502 | |
| Pubmed | Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. | 1.10e-05 | 3 | 67 | 2 | 24297939 | |
| Pubmed | 2.16e-05 | 28 | 67 | 3 | 18617019 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 2.19e-05 | 4 | 67 | 2 | 18983852 | |
| Pubmed | FLRT3 Marks Direction-Selective Retinal Ganglion Cells That Project to the Medial Terminal Nucleus. | 2.19e-05 | 4 | 67 | 2 | 34955746 | |
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 2.19e-05 | 4 | 67 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 2.19e-05 | 4 | 67 | 2 | 26253512 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 16872596 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 29024660 | ||
| Pubmed | Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. | 2.19e-05 | 4 | 67 | 2 | 18403710 | |
| Pubmed | Laminar and areal expression of unc5d and its role in cortical cell survival. | 2.19e-05 | 4 | 67 | 2 | 21216843 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 17456771 | ||
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 2.19e-05 | 4 | 67 | 2 | 25303118 | |
| Pubmed | Structural Basis of Teneurin-Latrophilin Interaction in Repulsive Guidance of Migrating Neurons. | 2.19e-05 | 4 | 67 | 2 | 31928845 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 29758265 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 25313870 | ||
| Pubmed | Genome-wide association study identifies two susceptibility loci for osteosarcoma. | 3.64e-05 | 5 | 67 | 2 | 23727862 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 17544870 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 37557174 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 15383666 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 15218527 | ||
| Pubmed | Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. | 3.64e-05 | 5 | 67 | 2 | 24851906 | |
| Pubmed | Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. | 3.64e-05 | 5 | 67 | 2 | 12839991 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 8817451 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 17878207 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 17977970 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18509452 | ||
| Pubmed | 5.19e-05 | 105 | 67 | 4 | 9628581 | ||
| Pubmed | Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. | 5.46e-05 | 6 | 67 | 2 | 19299310 | |
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 7.63e-05 | 7 | 67 | 2 | 20062055 | |
| Pubmed | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. | 7.63e-05 | 7 | 67 | 2 | 16527742 | |
| Pubmed | FLRT structure: balancing repulsion and cell adhesion in cortical and vascular development. | 7.63e-05 | 7 | 67 | 2 | 25374360 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 26335717 | ||
| Pubmed | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. | 7.63e-05 | 7 | 67 | 2 | 11863358 | |
| Pubmed | LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. | 7.63e-05 | 7 | 67 | 2 | 20463223 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 21835787 | ||
| Pubmed | Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. | 8.55e-05 | 44 | 67 | 3 | 12859895 | |
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 24227842 | ||
| Interaction | UNC5D interactions | 1.69e-06 | 8 | 64 | 3 | int:UNC5D | |
| Cytoband | 22q13.1-q13.2 | 1.26e-05 | 4 | 67 | 2 | 22q13.1-q13.2 | |
| GeneFamily | ADAMTS like | 4.05e-07 | 7 | 42 | 3 | 947 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 9.70e-07 | 9 | 42 | 3 | 430 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 2.53e-06 | 12 | 42 | 3 | 406 | |
| GeneFamily | UDP-glucose glycoprotein glucosyltransferases | 5.27e-06 | 2 | 42 | 2 | 440 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.10e-05 | 19 | 42 | 3 | 50 | |
| GeneFamily | Fibronectin type III domain containing | 5.09e-04 | 160 | 42 | 4 | 555 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 9.75e-04 | 20 | 42 | 2 | 736 | |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTSL1 COL17A1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A LOXL3 NYX SSPOP PLXNB1 ADAMTSL2 OTOG | 1.38e-07 | 1008 | 65 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTSL1 COL17A1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A LOXL3 NYX SSPOP PLXNB1 ADAMTSL2 OTOG | 1.72e-07 | 1026 | 65 | 14 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | 2.78e-05 | 238 | 65 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.05e-05 | 242 | 65 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A LOXL3 PLXNB1 ADAMTSL2 | 8.27e-05 | 738 | 65 | 9 | MM17058 |
| Coexpression | CHESLER_BRAIN_D6MIT150_QTL_CIS | 9.03e-05 | 6 | 65 | 2 | MM607 | |
| Coexpression | CHESLER_BRAIN_D6MIT150_QTL_CIS | 9.03e-05 | 6 | 65 | 2 | M12143 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTSL1 SEMA5B ADAMTS7 ADAMTS6 ADAMTS17 SEMA5A LOXL3 PLXNB1 ADAMTSL2 | 9.45e-05 | 751 | 65 | 9 | M5885 |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN | 1.37e-04 | 199 | 65 | 5 | M9832 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN | 1.40e-04 | 200 | 65 | 5 | M9928 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.56e-07 | 163 | 66 | 6 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-07 | 186 | 66 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-07 | 189 | 66 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-07 | 191 | 66 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.23e-07 | 193 | 66 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.36e-07 | 194 | 66 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 144 | 66 | 5 | cf9f049ab6cd80521598124f057c2debdde24788 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 144 | 66 | 5 | 41eaeca54b3c39de417597267cbdb1f195dd885a | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 169 | 66 | 5 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.54e-06 | 171 | 66 | 5 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.20e-06 | 175 | 66 | 5 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 175 | 66 | 5 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-06 | 178 | 66 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-06 | 186 | 66 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.55e-06 | 187 | 66 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 8.55e-06 | 187 | 66 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 192 | 66 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.72e-06 | 192 | 66 | 5 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 192 | 66 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 192 | 66 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 192 | 66 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 66 | 5 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 66 | 5 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.05e-05 | 195 | 66 | 5 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 195 | 66 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 195 | 66 | 5 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 195 | 66 | 5 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 195 | 66 | 5 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 198 | 66 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-05 | 200 | 66 | 5 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.05e-05 | 120 | 66 | 4 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.27e-05 | 138 | 66 | 4 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 140 | 66 | 4 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 140 | 66 | 4 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-05 | 146 | 66 | 4 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 148 | 66 | 4 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.10e-05 | 149 | 66 | 4 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.10e-05 | 149 | 66 | 4 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.67e-05 | 152 | 66 | 4 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.27e-05 | 155 | 66 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.48e-05 | 156 | 66 | 4 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.69e-05 | 157 | 66 | 4 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.13e-05 | 159 | 66 | 4 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-04 | 163 | 66 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-04 | 164 | 66 | 4 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 165 | 66 | 4 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 165 | 66 | 4 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 165 | 66 | 4 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 167 | 66 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 167 | 66 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 168 | 66 | 4 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.15e-04 | 169 | 66 | 4 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 66 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 170 | 66 | 4 | 021c3e45955d18e241f7d98acdf22076fee4fc43 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 171 | 66 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 171 | 66 | 4 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 171 | 66 | 4 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.24e-04 | 172 | 66 | 4 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.24e-04 | 172 | 66 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 173 | 66 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 174 | 66 | 4 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 174 | 66 | 4 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 175 | 66 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 175 | 66 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 175 | 66 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 175 | 66 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 175 | 66 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.35e-04 | 176 | 66 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-04 | 176 | 66 | 4 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-04 | 176 | 66 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-04 | 176 | 66 | 4 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 177 | 66 | 4 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 177 | 66 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.38e-04 | 177 | 66 | 4 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 177 | 66 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 177 | 66 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 177 | 66 | 4 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-04 | 178 | 66 | 4 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.41e-04 | 178 | 66 | 4 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-04 | 179 | 66 | 4 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 179 | 66 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 179 | 66 | 4 | 5bf191bdc0c32bce83ab5c38f0616e209e420e55 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 180 | 66 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 181 | 66 | 4 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 181 | 66 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 181 | 66 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 181 | 66 | 4 | cd46eba2e03fd15d8de8e875793ae2f51fa98b3b | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 181 | 66 | 4 | c7d12c7de227c9433ec2303b8929e957b833f59b | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 182 | 66 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 182 | 66 | 4 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| Drug | C0761 | 1.23e-06 | 8 | 65 | 3 | CID006321196 | |
| Drug | N-cyclopropylammelide | 1.23e-06 | 8 | 65 | 3 | CID000592814 | |
| Disease | Cobblestone Lissencephaly | 1.43e-05 | 3 | 65 | 2 | C0431376 | |
| Disease | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 4.76e-05 | 5 | 65 | 2 | cv:C4284790 | |
| Disease | lissencephaly (is_implicated_in) | 4.76e-05 | 5 | 65 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | Walker-Warburg syndrome (is_implicated_in) | 4.76e-05 | 5 | 65 | 2 | DOID:0050560 (is_implicated_in) | |
| Disease | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1 | 4.76e-05 | 5 | 65 | 2 | 236670 | |
| Disease | Qualitative or quantitative defects of alpha-dystroglycan | 7.13e-05 | 6 | 65 | 2 | cv:C2936406 | |
| Disease | Walker-Warburg syndrome (implicated_via_orthology) | 9.96e-05 | 7 | 65 | 2 | DOID:0050560 (implicated_via_orthology) | |
| Disease | osteosarcoma | 1.33e-04 | 8 | 65 | 2 | EFO_0000637 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 2.13e-04 | 10 | 65 | 2 | EFO_0008321 | |
| Disease | Congenital muscular dystrophy | 3.11e-04 | 12 | 65 | 2 | cv:C0699743 | |
| Disease | brain cortex volume measurement | 3.67e-04 | 13 | 65 | 2 | EFO_0010287 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 4.27e-04 | 14 | 65 | 2 | C1836373 | |
| Disease | alpha-Dystroglycanopathies | 4.27e-04 | 14 | 65 | 2 | C2936406 | |
| Disease | Muscle eye brain disease | 4.27e-04 | 14 | 65 | 2 | C0457133 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 4.27e-04 | 14 | 65 | 2 | C0410174 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 4.27e-04 | 14 | 65 | 2 | C4284790 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 4.93e-04 | 15 | 65 | 2 | C0265221 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.36e-04 | 17 | 65 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | inflammatory biomarker measurement | 1.50e-03 | 26 | 65 | 2 | EFO_0004872 | |
| Disease | 1,5 anhydroglucitol measurement | 1.87e-03 | 29 | 65 | 2 | EFO_0008009 | |
| Disease | glutamate measurement | 1.87e-03 | 29 | 65 | 2 | EFO_0010487 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.11e-03 | 115 | 65 | 3 | EFO_0007878, EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VWEEWGSWSLCSRSC | 366 | O60241 | |
| CPCGSCCSWWKWLLG | 456 | Q9UMD9 | |
| LALLWWFWPLCCTVI | 336 | Q9H6X2 | |
| SWSCWSSWSVCRAGI | 541 | P07357 | |
| TWFISWSPCFSWGCA | 276 | Q9UH17 | |
| SCSITWFLSWSPCWE | 81 | P41238 | |
| WFLSWSPCWECSQAI | 86 | P41238 | |
| RVTWFISWSPCFSWG | 91 | P31941 | |
| PWFCDCSIKWVTEWL | 311 | O43155 | |
| WSPWGAWSMCSRTCG | 546 | Q8TE56 | |
| WGPWSLWGECSRTCG | 561 | Q9UKP5 | |
| WSGWSAWSICSRSCG | 541 | Q9UKP4 | |
| ARWWAGEWQLCSSSC | 881 | Q9UKP4 | |
| PWDCGCRARSLWEWL | 256 | Q86UN2 | |
| NPWACDCRARPLWAW | 261 | Q86UN3 | |
| RWEDIGCALPWAWSG | 601 | Q8N239 | |
| VWQWSPWGLLLCLLC | 6 | P58215 | |
| RLWAGAGRWACWACQ | 21 | Q8N0U4 | |
| PCRTWWALFSTKPWC | 56 | Q8NFR9 | |
| DRDGLWDAWGPWSEC | 31 | Q8N6G6 | |
| WDAWGPWSECSRTCG | 36 | Q8N6G6 | |
| SSRWGCNWCVWQHLC | 646 | O43157 | |
| GTWNWIWRRCCRAAS | 31 | Q96E22 | |
| WAFLPDLCLCRVFWW | 16 | Q8N4B4 | |
| MDGRWQCSCWAWFLL | 1 | Q86TH1 | |
| CAGWALWRCALRWAE | 196 | P13985 | |
| ARCSQPEISWWGWRN | 231 | Q9NYA4 | |
| RFQWSCGSCWALWSS | 591 | Q7Z442 | |
| WWFWLTLTGVACSCA | 186 | Q9Y6A1 | |
| WLVAWSWSLDGLRDC | 31 | Q6ICH7 | |
| IWWCVLNWIPCGQSF | 156 | Q9NXB9 | |
| LTWGLPVSCSWFLWR | 26 | Q5T197 | |
| CLPWATAGAVRWWTC | 171 | Q9UBL6 | |
| SLVSGRWCAWWPEHC | 36 | Q9H8X3 | |
| LWLYQNDGCLWWSPC | 306 | P19235 | |
| LGWCNSWPSTVWHCF | 201 | O60381 | |
| DMCCWWVGPWHAIVR | 86 | Q08477 | |
| IFTWWEPWQDCNRCE | 141 | Q17R55 | |
| PWFCGCNLMWLRDWV | 301 | Q9NZU1 | |
| RCGRWNLWEASFCGW | 341 | Q9NVP4 | |
| SSRPLLCWSVWWALS | 291 | O60779 | |
| LCWSVWWALSTCGYF | 296 | O60779 | |
| TSWWPGACLCSSCAW | 6 | Q6W349 | |
| SALCWLLCVWLPWGE | 6 | Q6ZRI0 | |
| NPWCCDCRLEWLRDW | 336 | Q9GZU5 | |
| LPSCLWFRGTGLIWW | 251 | Q9H720 | |
| ARWVFFCQLCSWFTW | 171 | Q92521 | |
| GSGWNFCSIPWCLFW | 231 | P59025 | |
| RGCLRTWFQRWWDCS | 751 | A8K8P3 | |
| VCLPLWISWAEWSEG | 436 | Q9NYH9 | |
| SWWCVFWDLYCAAPE | 61 | Q9BWW4 | |
| RPCIWWKLCWSFFTP | 491 | P30531 | |
| LEECCARPWGQSWWD | 136 | A2VEC9 | |
| DCAVDCGWSSWSPWA | 1906 | A2VEC9 | |
| ERCPVACGWSPWTLW | 2981 | A2VEC9 | |
| ACGWSPWTLWSLCSC | 2986 | A2VEC9 | |
| CADRPFSAPWWFWLS | 216 | Q9UKY4 | |
| PLFWTWLTICCAVWR | 136 | Q5T036 | |
| RGCCWRPWNDSLIPW | 91 | P14410 | |
| DGVWSCWSPWTKCSA | 841 | Q13591 | |
| LAAVAAWVPCRSWGW | 6 | Q9NUJ1 | |
| CPWWLCFDWSMGCIP | 331 | Q5T4D3 | |
| WKCPWCKAINFSWRT | 681 | A0A0J9YY54 | |
| DPWNAFWFCLAWCTF | 776 | Q8N271 | |
| PSSASWRCALWHRVW | 761 | Q9H6E5 | |
| LGLCTWWSWCRTFDP | 251 | Q9H5I5 | |
| WWSWCRTFDPLLFSC | 256 | Q9H5I5 | |
| CSRNGAWTPWSSWAL | 661 | Q9P283 | |
| WAAWGPWSSCSRDCE | 856 | Q9P283 | |
| RWLPWLGLCFWAAGT | 16 | Q6UXZ4 | |
| KSLPQDWLWCETWCD | 1441 | Q9NYU1 | |
| SWCSWGLWPEIRKCK | 451 | Q9UJV3 | |
| WGAWGPWSACSRSCS | 56 | Q6ZMP0 | |
| FSPGWFWRICWVAIS | 531 | P31645 | |
| WTGSWDASKPRASCW | 2251 | P01266 | |
| KSLPQEWLWCETWCD | 1466 | Q9NYU2 |